Tevogen Bio (G280.F) Q2 2026 Earnings

3JunConfirmed
Q1 2026
Next
-2.25
-1.93
-1.61
-1.3

Details

Expected EPS
-2.251656
Actual EPS
N/A
Surprise EPS
2.25
Surprise Percent
+100%

Description

Tevogen Bio (G280.F) will report earnings of for Q2 2026 on June 03, 2026.

0 Comments

Share your thoughts